Capital A Leverages Ant International’s AI-Enabled FX Solution to Optimise Treasury Operations and Enhance Customer Experience
Ant International’s proprietary Falcon Time-Series Transformer (TST) Model forecasted Capital A’s sales and FX exposures to manage FX costs more efficientlyEnhanced FX strategy reduced Capital A’s FX hedging costs by up to 40%
Capital A has partnered with Ant International to optimise treasury operations and enhance customer experience for its airline business, AirAsia. By leveraging Ant International’s proprietary Falcon Time-Series Transformer (TST) Model, Capital A was able to better manage AirAsia's cash flows across multiple currencies and in turn, offer more stable, competitive pricing to its customers.
This was enabled by Falcon, which enhanced AirAsia’s FX risk management and reduced its hedging costs by up to 40%, allowing the airline to pass the cost savings on to customers through more competitive FX rates. The integration also resulted in a more future-proof and scalable treasury management solution for AirAsia, with 90% accuracy in forecasting the company's cashflow and FX exposure on an hourly, daily and weekly basis.
This integration marks the first industry-tailored solution that Ant International has developed from Falcon. Following the launch in April, Ant applied the large data model to various treasury management scenarios to design solutions for specialised industries, such as airlines. The model was trained on 2 billion parameters, including 80 million parameters of travel-related data, such as open-sourced data from OTAs and air carriers. This enabled Ant to launch an AI FX offering catered to the airline industry.
The solution was then integrated with Capital A’s corporate banking partner’s fixed FX rate infrastructure to complete transactions for AirAsia. Ant International estimates that in time, the enhanced solution could help the broader airline industry reduce its overall FX costs by as much as 60% for selected currency pairs.
Aireen Omar, Group Chief Executive Officer, BigPay, said: “As a group, we serve over 70 million travellers yearly, 35 million AirAsia Rewards members and our fintech arm, BigPay has over 1.6 million carded users. Through our partnership with Ant International, we are able to reduce the hedging cost by 40%. This helps us immensely as Capital A processes massive multicurrency volumes every day and this platform updates FX rates twice daily and provides great margin management capability.
Kelvin Li, General Manager of Platform Tech at Ant International, said: “Our partnership with Capital A marks the first commercial deployment of Falcon, an important milestone in our journey to transform treasury and FX management for businesses. The results demonstrate how innovation, technology and institutional-grade execution solve real-world FX challenges and reshape cross-border payments. We look forward to serving more businesses and industries as we continue to build on our enterprise embedded finance solutions.”
According to a report from McKinsey1, the airline industry processes about 2.9 billion payment transactions annually, valued at $1 trillion. Despite the scale of payment processing the sector is involved in, there is a lack of tailored solutions from the payments industry that enable airlines to lower its associated payment costs. Airlines spend over $20 billion annually on payment-related expenses, accounting for 3% of the industry’s total revenue.
With airline travel set to continue growing to 5.2 billion passengers this year as estimated by IATA, Capital A and Ant International recognise the need for enhanced solutions that will allow the industry to improve their FX risk management and lower costs, by leveraging AI. Both sides will continue to explore more efficient and transparent global fund management solutions via Ant International's Bettr Treasury Platform.
About Capital A
Capital A is an investment holding company with a diverse portfolio of synergistic aviation and travel businesses, leveraging data and technology to drive growth. Our key businesses include AirAsia, the world’s leading low-cost carrier, Capital A Aviation Services Group, AirAsia MOVE (formerly airasia Superapp) and fintech BigPay as well as logistics venture Teleport and brand development company, Abc. Capital A’s vision is to create and deliver products and services that focus on offering the best value at the lowest cost, underpinned by robust data accumulated over 20 years in operation and one of Asia's leading brands that remains committed to serving the underserved in Asean and beyond.
About Ant International
With headquarters in Singapore and main operations across Asia, Europe, the Middle East and Latin America, Ant International is a leading global digital payment, digitisation and financial technology provider. Through collaboration across the private and public sectors, our unified techfin platform supports financial institutions and merchants of all sizes to achieve inclusive growth through a comprehensive range of cutting-edge digital payment and financial services solutions. To learn more, please visit https://www.ant-intl.com/
1 Airline retailing: How payment innovation can improve the bottom line (2022) https://www.mckinsey.com/industries/travel/our-insights/airline-retailing-how-payment-innovation-can-improve-the-bottom-line
View source version on businesswire.com: https://www.businesswire.com/news/home/20251006353902/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SIAL Paris 2026 : The Entire Food Industry in One Place – An Unmissable Event for Professionals8.12.2025 09:00:00 CET | Press release
SIAL Paris 2026 is more than ever the world’s must-attend food industry event With less than a year to go, SIAL Parisonce again stands as a key international gathering for food industry professionals. With 85% of exhibition space already booked, the show demonstrates very strong momentum and appeal. SIAL Paris will welcome 295,000 professionals from 200 countries across a stunning 280,000 m² of exhibition space, covering all sectors of the food industry. Innovation at the core of global food transformation In a context marked by major demographic, environmental and geopolitical challenges, SIAL Paris stands as THE hub where innovation drives action, business, and transformation. It brings across all sectors’ ideas, projects, and solutions that address today’s challenges, all while inspiring food business around the world. As in every edition, the show will offer a unique immersive experience, facilitating meaningful meetings and business opportunities. SIAL Paris serves as the global i
Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 20268.12.2025 08:00:00 CET | Press release
Merz Therapeutics to present more than 20 abstracts and posters at the TOXINS 2026 8th International Conference, taking place January 14-17 2026 in Madrid, Spain. Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced that the company will present more than 20 clinical and non-clinical abstracts and posters spanning spasticity, movement disorders, and neurotoxin science at the TOXINS 2026 8th International Conference, taking place January 14–17, 2026, in Madrid, Spain. These presentations underscore the company’s commitment to addressing unmet needs in neurological disorders. “Our research reflects a relentless focus on improving patient outcomes through innovation in neurotoxin science,” said Dr. Stefan Albrecht, Chief Scientific and Medical Officer at Merz Therapeutics. “By presenting these new data at TOXINS 2026, we aim to foster scientific exchange and advance treatment strategies that address real-world challenges for patients and clinicians.”
Galderma Welcomes Increased Equity Investment From L’Oréal8.12.2025 07:05:00 CET | Press release
L’Oréal to acquire an additional 10% stake in Galderma recognizing its scientific leadership in dermatology and long-term growth potential Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers). Following the transaction, which is subject to customary approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The transaction is expected to close in Q1 2026. In connection with this increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal, replacing the board members representing the consortium led by EQT, at the 2026 Annual General Meeting. Additio
Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 04:37:00 CET | Press release
The Challenge: Deepfakes undermine both the accuracy and fairness of AI face detection due to variations in human features.The Technology: Ant International’s AI model uses a novel ‘Mixture of Experts’-based Adversarial Debiasing approach to achieve superior fairness and accuracy across diverse demographics.The Impact: This advancement strengthens payment security, offering robust protection against deepfake fraud and enhancing eKYC compliance globally. Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the Nati
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom